TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 32.9% | 34.2% | 36.9% | 32.0% | 33.5% | 36.4% | 36.3% | 34.8% | 34.2% | 45.6% | 51.2% | 33.3% | 41.0% | |
| 67.1% | 65.8% | 63.1% | 68.0% | 66.5% | 63.6% | 63.7% | 65.2% | 65.8% | 54.4% | 48.8% | 66.7% | 59.0% | |
| 17.6% | 16.9% | 18.6% | 13.9% | 14.9% | 14.9% | 20.5% | 13.0% | 14.5% | 14.7% | 17.8% | 13.7% | 15.2% | |
| 24.3% | 24.1% | 27.1% | 22.4% | 22.8% | 23.7% | 28.1% | 23.1% | 22.8% | 23.3% | 26.2% | 23.5% | 23.9% | |
| 71.8% | 56.4% | 64.1% | 54.2% | 50.8% | 57.7% | 70.8% | 48.6% | 59.6% | 38.4% | 44.5% | 50.2% | 48.0% | |
| -4.7% | 9.4% | -1.0% | 13.8% | 15.7% | 5.9% | -7.1% | 16.7% | 6.2% | 16.0% | 4.3% | 16.5% | 11.0% | |
| 0.0% | 6.0% | 0.0% | 4.9% | 5.8% | 0.0% | 0.0% | 9.7% | 7.5% | 10.4% | 4.0% | 5.2% | 6.8% | |
| -9.2% | 5.5% | -4.5% | 11.3% | 10.2% | 2.3% | -10.2% | 13.6% | 2.5% | 11.2% | -4.8% | 13.3% | 5.9% | |
| -4.6% | -4.0% | -4.2% | 3.4% | 2.3% | 0.2% | -0.4% | 2.4% | 3.6% | 2.5% | -2.6% | 4.1% | 2.0% | |
| -4.6% | 9.5% | -0.3% | 7.9% | 7.8% | 2.1% | -9.8% | 11.2% | -1.1% | 8.7% | -2.2% | 9.3% | 3.9% | |
| 19.4% | 23.1% | 24.7% | 32.2% | 32.3% | 16.9% | 17.2% | 39.7% | 28.4% | 37.6% | 14.2% | 27.7% | 27.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.